| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autophagy | 22 | 2021 | 159 | 6.000 |
Why?
|
| Retinoblastoma Protein | 12 | 2010 | 64 | 2.560 |
Why?
|
| Microtubule-Associated Proteins | 7 | 2021 | 184 | 2.440 |
Why?
|
| Membrane Proteins | 10 | 2021 | 1227 | 2.400 |
Why?
|
| Mitochondrial Proteins | 7 | 2021 | 127 | 2.250 |
Why?
|
| Mitochondria | 8 | 2021 | 556 | 1.950 |
Why?
|
| Neoplasms | 13 | 2021 | 3065 | 1.940 |
Why?
|
| Proto-Oncogene Proteins | 8 | 2021 | 665 | 1.790 |
Why?
|
| Tumor Microenvironment | 5 | 2023 | 476 | 1.060 |
Why?
|
| Cell Movement | 4 | 2018 | 786 | 1.040 |
Why?
|
| Focal Adhesions | 2 | 2016 | 70 | 1.020 |
Why?
|
| Neoplasm Metastasis | 9 | 2021 | 1066 | 1.010 |
Why?
|
| Lipid Metabolism | 2 | 2019 | 201 | 0.970 |
Why?
|
| Genes, Retinoblastoma | 7 | 2010 | 21 | 0.960 |
Why?
|
| Carcinogenesis | 3 | 2021 | 213 | 0.900 |
Why?
|
| Animals | 54 | 2024 | 27526 | 0.850 |
Why?
|
| Neoplastic Stem Cells | 4 | 2019 | 162 | 0.840 |
Why?
|
| Autophagy-Related Protein-1 Homolog | 1 | 2021 | 3 | 0.790 |
Why?
|
| Erythroblasts | 5 | 2007 | 25 | 0.780 |
Why?
|
| Homeostasis | 7 | 2024 | 418 | 0.780 |
Why?
|
| Cell Cycle | 10 | 2016 | 508 | 0.760 |
Why?
|
| DNA Damage | 7 | 2017 | 373 | 0.750 |
Why?
|
| Mice | 34 | 2023 | 11851 | 0.720 |
Why?
|
| ras Proteins | 2 | 2019 | 130 | 0.710 |
Why?
|
| Erythropoiesis | 6 | 2007 | 51 | 0.690 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 387 | 0.660 |
Why?
|
| Paxillin | 2 | 2016 | 58 | 0.650 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2014 | 153 | 0.650 |
Why?
|
| Liver | 3 | 2021 | 1211 | 0.610 |
Why?
|
| Mitochondria, Liver | 3 | 2021 | 28 | 0.610 |
Why?
|
| Hematopoiesis | 3 | 2008 | 168 | 0.610 |
Why?
|
| Neurodegenerative Diseases | 2 | 2016 | 51 | 0.600 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2015 | 127 | 0.580 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2016 | 98 | 0.570 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2025 | 120 | 0.560 |
Why?
|
| Pancreatic Neoplasms | 4 | 2025 | 684 | 0.560 |
Why?
|
| Inflammation | 3 | 2017 | 981 | 0.550 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2017 | 168 | 0.530 |
Why?
|
| Muscular Atrophy | 1 | 2016 | 46 | 0.530 |
Why?
|
| src-Family Kinases | 1 | 2016 | 74 | 0.530 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 50 | 0.520 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2019 | 605 | 0.510 |
Why?
|
| Signal Transduction | 11 | 2024 | 3403 | 0.500 |
Why?
|
| Oxidative Stress | 4 | 2017 | 458 | 0.490 |
Why?
|
| Macrophages | 3 | 2007 | 582 | 0.470 |
Why?
|
| Humans | 46 | 2025 | 89924 | 0.470 |
Why?
|
| Stress, Physiological | 3 | 2024 | 232 | 0.450 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2021 | 289 | 0.440 |
Why?
|
| Cell Line, Tumor | 10 | 2023 | 2587 | 0.440 |
Why?
|
| Flow Cytometry | 3 | 2010 | 690 | 0.430 |
Why?
|
| Fibroblasts | 2 | 2014 | 759 | 0.430 |
Why?
|
| Mice, Knockout | 10 | 2021 | 2015 | 0.410 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2025 | 1283 | 0.400 |
Why?
|
| Hypoxia | 2 | 2007 | 657 | 0.390 |
Why?
|
| Cells, Cultured | 8 | 2021 | 2887 | 0.370 |
Why?
|
| Phagosomes | 2 | 2010 | 39 | 0.370 |
Why?
|
| Carcinoma | 1 | 2014 | 438 | 0.350 |
Why?
|
| Cell Differentiation | 8 | 2007 | 1533 | 0.340 |
Why?
|
| Mice, Transgenic | 6 | 2021 | 1576 | 0.330 |
Why?
|
| Erythrocytes | 5 | 2007 | 254 | 0.330 |
Why?
|
| Gene Expression Regulation | 9 | 2021 | 1983 | 0.330 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2009 | 51 | 0.330 |
Why?
|
| Phosphorylation | 3 | 2021 | 1130 | 0.320 |
Why?
|
| Mitochondrial Dynamics | 2 | 2021 | 56 | 0.320 |
Why?
|
| Apoptosis | 8 | 2010 | 1718 | 0.310 |
Why?
|
| E2F Transcription Factors | 2 | 2007 | 19 | 0.300 |
Why?
|
| E2F2 Transcription Factor | 1 | 2007 | 4 | 0.300 |
Why?
|
| Mammary Glands, Animal | 3 | 2018 | 80 | 0.300 |
Why?
|
| Models, Biological | 7 | 2016 | 1765 | 0.280 |
Why?
|
| Cell Adhesion | 3 | 2018 | 426 | 0.280 |
Why?
|
| Biological Assay | 3 | 2021 | 79 | 0.270 |
Why?
|
| Cell Communication | 1 | 2007 | 200 | 0.270 |
Why?
|
| Amino Acid Motifs | 2 | 2016 | 117 | 0.260 |
Why?
|
| Breast Neoplasms | 3 | 2018 | 3021 | 0.260 |
Why?
|
| Carrier Proteins | 3 | 2018 | 678 | 0.260 |
Why?
|
| Cyclins | 2 | 1996 | 82 | 0.260 |
Why?
|
| Aging | 2 | 2016 | 727 | 0.260 |
Why?
|
| Myelopoiesis | 1 | 2005 | 10 | 0.250 |
Why?
|
| MAP Kinase Kinase 4 | 3 | 2011 | 64 | 0.240 |
Why?
|
| Antineoplastic Agents | 4 | 2019 | 2331 | 0.230 |
Why?
|
| Cell Proliferation | 4 | 2017 | 1669 | 0.230 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2015 | 449 | 0.230 |
Why?
|
| Cell Nucleus | 5 | 2017 | 602 | 0.220 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 156 | 0.210 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2019 | 165 | 0.210 |
Why?
|
| Prostatic Neoplasms | 2 | 2011 | 1738 | 0.210 |
Why?
|
| Pancreas | 1 | 2024 | 253 | 0.200 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 313 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 6 | 2017 | 961 | 0.200 |
Why?
|
| HEK293 Cells | 2 | 2021 | 646 | 0.200 |
Why?
|
| Protein Binding | 4 | 2017 | 1491 | 0.200 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 2393 | 0.190 |
Why?
|
| Blotting, Western | 3 | 2015 | 793 | 0.190 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2021 | 108 | 0.190 |
Why?
|
| Reactive Oxygen Species | 3 | 2015 | 490 | 0.190 |
Why?
|
| Autophagosomes | 2 | 2021 | 3 | 0.180 |
Why?
|
| Glucagon | 1 | 2021 | 111 | 0.180 |
Why?
|
| Autophagy-Related Proteins | 2 | 2021 | 21 | 0.180 |
Why?
|
| Cytosol | 1 | 2021 | 193 | 0.180 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 200 | 0.180 |
Why?
|
| Genes, p53 | 2 | 1999 | 109 | 0.170 |
Why?
|
| Autophagy-Related Protein 7 | 2 | 2017 | 12 | 0.170 |
Why?
|
| Genome, Mitochondrial | 1 | 2019 | 28 | 0.170 |
Why?
|
| Adenosine Triphosphate | 2 | 2012 | 316 | 0.170 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2019 | 14 | 0.170 |
Why?
|
| Base Sequence | 10 | 2017 | 2329 | 0.160 |
Why?
|
| Cell Death | 4 | 2008 | 261 | 0.160 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2019 | 37 | 0.160 |
Why?
|
| DNA, Mitochondrial | 1 | 2019 | 189 | 0.160 |
Why?
|
| Point Mutation | 1 | 2019 | 245 | 0.160 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 1801 | 0.160 |
Why?
|
| Glycolysis | 2 | 2019 | 135 | 0.160 |
Why?
|
| Neoplasm Invasiveness | 2 | 2018 | 569 | 0.160 |
Why?
|
| Thiolester Hydrolases | 1 | 2018 | 14 | 0.150 |
Why?
|
| Sequestosome-1 Protein | 2 | 2015 | 22 | 0.150 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2017 | 412 | 0.150 |
Why?
|
| Globins | 5 | 1991 | 31 | 0.150 |
Why?
|
| Disease Progression | 3 | 2015 | 1469 | 0.140 |
Why?
|
| Embryo, Mammalian | 4 | 2004 | 223 | 0.140 |
Why?
|
| Neoplasms, Experimental | 1 | 1999 | 269 | 0.140 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2017 | 90 | 0.140 |
Why?
|
| RNA, Messenger | 2 | 2021 | 2026 | 0.140 |
Why?
|
| Anoikis | 1 | 2016 | 8 | 0.140 |
Why?
|
| STAT3 Transcription Factor | 1 | 2017 | 86 | 0.140 |
Why?
|
| Immunologic Surveillance | 1 | 2016 | 14 | 0.140 |
Why?
|
| Genetic Therapy | 1 | 2019 | 372 | 0.140 |
Why?
|
| Protein Interaction Maps | 1 | 2016 | 50 | 0.130 |
Why?
|
| Protein Transport | 2 | 2016 | 423 | 0.130 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 245 | 0.130 |
Why?
|
| Adaptation, Biological | 1 | 2017 | 85 | 0.130 |
Why?
|
| Tumor Escape | 1 | 2016 | 51 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2017 | 189 | 0.130 |
Why?
|
| Protein Stability | 1 | 2016 | 101 | 0.130 |
Why?
|
| Oxidation-Reduction | 2 | 2019 | 388 | 0.130 |
Why?
|
| S Phase | 4 | 2007 | 63 | 0.130 |
Why?
|
| Ultraviolet Rays | 1 | 2017 | 195 | 0.130 |
Why?
|
| Lysosomes | 2 | 2021 | 113 | 0.130 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 173 | 0.130 |
Why?
|
| Molecular Sequence Data | 8 | 2007 | 3024 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 247 | 0.120 |
Why?
|
| Cytoskeletal Proteins | 1 | 2016 | 228 | 0.120 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2015 | 11 | 0.120 |
Why?
|
| Carcinoma in Situ | 1 | 2015 | 52 | 0.120 |
Why?
|
| Energy Metabolism | 1 | 2017 | 282 | 0.120 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2015 | 57 | 0.120 |
Why?
|
| Cytoskeleton | 1 | 2016 | 195 | 0.120 |
Why?
|
| Macrolides | 1 | 2015 | 30 | 0.120 |
Why?
|
| Amino Acid Sequence | 2 | 2016 | 2063 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2015 | 3470 | 0.120 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 156 | 0.120 |
Why?
|
| Biomarkers | 3 | 2021 | 1775 | 0.110 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 318 | 0.110 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2014 | 117 | 0.110 |
Why?
|
| Epithelial Cells | 1 | 2018 | 689 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 1091 | 0.110 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2014 | 160 | 0.110 |
Why?
|
| Skin | 1 | 2017 | 589 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 354 | 0.110 |
Why?
|
| Prognosis | 2 | 2025 | 3796 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2008 | 79 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 586 | 0.100 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1992 | 9 | 0.100 |
Why?
|
| E2F1 Transcription Factor | 2 | 2010 | 13 | 0.100 |
Why?
|
| Genetic Heterogeneity | 2 | 2025 | 67 | 0.100 |
Why?
|
| Gluconeogenesis | 1 | 2012 | 14 | 0.100 |
Why?
|
| Head and Neck Neoplasms | 1 | 2019 | 1061 | 0.100 |
Why?
|
| Lipogenesis | 1 | 2012 | 23 | 0.100 |
Why?
|
| Mouth Neoplasms | 1 | 2014 | 198 | 0.100 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 64 | 0.100 |
Why?
|
| Lactams, Macrocyclic | 1 | 2011 | 13 | 0.100 |
Why?
|
| Benzoquinones | 1 | 2011 | 26 | 0.100 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2011 | 17 | 0.100 |
Why?
|
| Fasting | 1 | 2012 | 162 | 0.100 |
Why?
|
| Fatty Acids | 1 | 2012 | 134 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 2 | 2010 | 434 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2008 | 125 | 0.090 |
Why?
|
| Fatty Liver | 1 | 2012 | 99 | 0.090 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 245 | 0.090 |
Why?
|
| DNA-Binding Proteins | 6 | 1998 | 1244 | 0.090 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2011 | 66 | 0.090 |
Why?
|
| Orchiectomy | 1 | 2010 | 62 | 0.090 |
Why?
|
| Tissue Distribution | 2 | 2005 | 293 | 0.090 |
Why?
|
| Sirolimus | 1 | 2011 | 162 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 603 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2025 | 1452 | 0.090 |
Why?
|
| Receptors, Androgen | 1 | 2010 | 119 | 0.090 |
Why?
|
| Propidium | 1 | 2009 | 7 | 0.080 |
Why?
|
| Microscopy, Electron | 1 | 2010 | 511 | 0.080 |
Why?
|
| Female | 10 | 2019 | 46571 | 0.080 |
Why?
|
| NAD | 1 | 2009 | 72 | 0.080 |
Why?
|
| Embryonic and Fetal Development | 2 | 2001 | 72 | 0.080 |
Why?
|
| Contrast Media | 1 | 2014 | 1084 | 0.080 |
Why?
|
| Glucose | 1 | 2012 | 629 | 0.080 |
Why?
|
| Gene Expression | 2 | 2014 | 1309 | 0.080 |
Why?
|
| Nucleotides | 1 | 2009 | 98 | 0.080 |
Why?
|
| Necrosis | 1 | 2009 | 210 | 0.080 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2009 | 78 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2012 | 3252 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2008 | 23 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2008 | 726 | 0.080 |
Why?
|
| Cell Survival | 2 | 2007 | 983 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 3 | 2018 | 1048 | 0.070 |
Why?
|
| Fetal Viability | 1 | 2007 | 9 | 0.070 |
Why?
|
| Deferoxamine | 1 | 2007 | 18 | 0.070 |
Why?
|
| Eukaryotic Cells | 1 | 2007 | 44 | 0.070 |
Why?
|
| Siderophores | 1 | 2007 | 22 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 919 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 1 | 2008 | 171 | 0.070 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2007 | 76 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 2362 | 0.070 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2007 | 12 | 0.070 |
Why?
|
| Longevity | 1 | 2007 | 58 | 0.070 |
Why?
|
| Binding Sites | 4 | 1995 | 1121 | 0.070 |
Why?
|
| Chimera | 2 | 2004 | 56 | 0.070 |
Why?
|
| Integrases | 1 | 2007 | 63 | 0.070 |
Why?
|
| Mitosis | 1 | 2007 | 152 | 0.070 |
Why?
|
| Cisplatin | 1 | 2009 | 598 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 1544 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 1098 | 0.070 |
Why?
|
| Transcription Factors | 4 | 1998 | 1665 | 0.070 |
Why?
|
| Guidelines as Topic | 1 | 2007 | 158 | 0.070 |
Why?
|
| Sequence Alignment | 1 | 2007 | 354 | 0.070 |
Why?
|
| Mice, Inbred Strains | 2 | 2004 | 308 | 0.070 |
Why?
|
| Cell Line | 3 | 2009 | 2495 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2007 | 198 | 0.070 |
Why?
|
| Placenta | 1 | 2007 | 181 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 302 | 0.060 |
Why?
|
| Mutation | 4 | 2019 | 4165 | 0.060 |
Why?
|
| U937 Cells | 1 | 2005 | 32 | 0.060 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 2369 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 693 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 139 | 0.060 |
Why?
|
| Anemia, Aplastic | 1 | 2004 | 32 | 0.060 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2005 | 93 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2005 | 272 | 0.060 |
Why?
|
| DNA, Neoplasm | 1 | 2005 | 266 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2004 | 178 | 0.060 |
Why?
|
| RNA Interference | 2 | 2018 | 376 | 0.060 |
Why?
|
| Lymphoma | 1 | 2005 | 266 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2005 | 520 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2025 | 241 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 740 | 0.050 |
Why?
|
| Arginine | 1 | 2023 | 138 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 885 | 0.050 |
Why?
|
| Male | 4 | 2019 | 42657 | 0.050 |
Why?
|
| Time Factors | 2 | 2018 | 5357 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 389 | 0.050 |
Why?
|
| Leukemia | 1 | 2005 | 322 | 0.050 |
Why?
|
| Amino Acids | 1 | 2023 | 246 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 1130 | 0.050 |
Why?
|
| Transcriptional Activation | 2 | 1994 | 294 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 771 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2767 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 2506 | 0.050 |
Why?
|
| Phenotype | 1 | 2007 | 2457 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2011 | 122 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2021 | 277 | 0.040 |
Why?
|
| Cell Division | 2 | 2008 | 692 | 0.040 |
Why?
|
| NADP | 1 | 2019 | 45 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 237 | 0.040 |
Why?
|
| Brain | 2 | 2001 | 2304 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 397 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2019 | 269 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 1255 | 0.040 |
Why?
|
| Fetal Proteins | 1 | 2018 | 17 | 0.040 |
Why?
|
| Acyl Coenzyme A | 1 | 2018 | 17 | 0.040 |
Why?
|
| Fibrillar Collagens | 1 | 2018 | 10 | 0.040 |
Why?
|
| Madin Darby Canine Kidney Cells | 1 | 2018 | 19 | 0.040 |
Why?
|
| A549 Cells | 1 | 2018 | 42 | 0.040 |
Why?
|
| Lipoylation | 1 | 2018 | 30 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2019 | 495 | 0.040 |
Why?
|
| Cell Shape | 1 | 2018 | 51 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2018 | 114 | 0.040 |
Why?
|
| Mice, Nude | 2 | 2011 | 816 | 0.040 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2018 | 84 | 0.040 |
Why?
|
| Myosins | 1 | 2018 | 92 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 280 | 0.030 |
Why?
|
| Molecular Docking Simulation | 1 | 2017 | 49 | 0.030 |
Why?
|
| Peripheral Nervous System | 1 | 1996 | 21 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2017 | 70 | 0.030 |
Why?
|
| Cellular Microenvironment | 1 | 2017 | 29 | 0.030 |
Why?
|
| Dogs | 1 | 2018 | 706 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 1996 | 130 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 68 | 0.030 |
Why?
|
| Lymphangiogenesis | 1 | 2017 | 39 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 82 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2017 | 99 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 65 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2018 | 515 | 0.030 |
Why?
|
| Epidermis | 1 | 2017 | 102 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2018 | 207 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2017 | 132 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 143 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 490 | 0.030 |
Why?
|
| Central Nervous System | 1 | 1996 | 153 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 1998 | 399 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1995 | 43 | 0.030 |
Why?
|
| Kinetics | 1 | 2018 | 1534 | 0.030 |
Why?
|
| Culture Media | 1 | 1995 | 147 | 0.030 |
Why?
|
| Breast | 1 | 2017 | 292 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1992 | 173 | 0.030 |
Why?
|
| Actins | 1 | 2018 | 462 | 0.030 |
Why?
|
| Lipoxygenase | 3 | 1990 | 8 | 0.030 |
Why?
|
| Glutathione Peroxidase | 3 | 1990 | 24 | 0.030 |
Why?
|
| Injections | 1 | 2014 | 116 | 0.030 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2014 | 6 | 0.030 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2014 | 31 | 0.030 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2014 | 104 | 0.030 |
Why?
|
| Quinoxalines | 1 | 2014 | 50 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 64 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2014 | 126 | 0.030 |
Why?
|
| Genes | 3 | 1989 | 306 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 2014 | 256 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 727 | 0.030 |
Why?
|
| Perfusion | 1 | 2014 | 253 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 268 | 0.030 |
Why?
|
| Cytokines | 1 | 2017 | 811 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 341 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1996 | 663 | 0.030 |
Why?
|
| Transfection | 2 | 1991 | 909 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 1158 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1992 | 93 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2014 | 319 | 0.020 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1991 | 30 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1992 | 154 | 0.020 |
Why?
|
| eIF-2 Kinase | 1 | 2011 | 48 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2015 | 550 | 0.020 |
Why?
|
| Glutathione | 1 | 2011 | 108 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2011 | 47 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2016 | 1102 | 0.020 |
Why?
|
| G1 Phase | 1 | 2011 | 65 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 323 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1991 | 283 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1992 | 306 | 0.020 |
Why?
|
| Fetal Death | 2 | 2001 | 57 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1992 | 284 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 1994 | 559 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 255 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2011 | 310 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 557 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 279 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 6780 | 0.020 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1988 | 36 | 0.020 |
Why?
|
| Pseudogenes | 1 | 1988 | 34 | 0.020 |
Why?
|
| Hemagglutinins | 1 | 2008 | 19 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2008 | 85 | 0.020 |
Why?
|
| Autophagy-Related Protein 8 Family | 1 | 2007 | 2 | 0.020 |
Why?
|
| Omentum | 1 | 2008 | 74 | 0.020 |
Why?
|
| Transgenes | 1 | 2008 | 185 | 0.020 |
Why?
|
| Permeability | 1 | 2007 | 138 | 0.020 |
Why?
|
| Plants | 1 | 2007 | 116 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 2007 | 117 | 0.020 |
Why?
|
| Erythropoietin | 1 | 2007 | 90 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1988 | 217 | 0.020 |
Why?
|
| DNA | 1 | 1991 | 1311 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2007 | 383 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2007 | 286 | 0.020 |
Why?
|
| Rats | 1 | 2011 | 4048 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 19240 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2001 | 72 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 26132 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 26810 | 0.010 |
Why?
|
| Gestational Age | 1 | 2001 | 329 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2001 | 524 | 0.010 |
Why?
|
| Transcription Factor DP1 | 1 | 1998 | 5 | 0.010 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 1998 | 10 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1998 | 171 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1998 | 471 | 0.010 |
Why?
|
| Quail | 1 | 1994 | 8 | 0.010 |
Why?
|
| PAX6 Transcription Factor | 1 | 1994 | 10 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 1994 | 24 | 0.010 |
Why?
|
| Pregnancy | 1 | 2001 | 3040 | 0.010 |
Why?
|
| Paired Box Transcription Factors | 1 | 1994 | 52 | 0.010 |
Why?
|
| Genotype | 1 | 1998 | 1853 | 0.010 |
Why?
|
| Eye Proteins | 1 | 1994 | 128 | 0.010 |
Why?
|
| Lung | 1 | 1998 | 1292 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 1994 | 423 | 0.010 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 1989 | 4 | 0.010 |
Why?
|
| Porphyrias | 1 | 1988 | 1 | 0.010 |
Why?
|
| Chickens | 1 | 1989 | 212 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1988 | 243 | 0.000 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1988 | 147 | 0.000 |
Why?
|
| Plasmids | 1 | 1989 | 291 | 0.000 |
Why?
|
| Cloning, Molecular | 1 | 1988 | 645 | 0.000 |
Why?
|
| Rabbits | 1 | 1988 | 640 | 0.000 |
Why?
|
| Acute Disease | 1 | 1988 | 846 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1988 | 1074 | 0.000 |
Why?
|
| Biological Evolution | 1 | 1988 | 974 | 0.000 |
Why?
|